SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7930Preliminary Results Show Improvement for Insomnia Patients with Co-Existing DeprIcebrg-1/12/2005
7929Impressive performance today: After being down about $2 on the FDA paperwork snbiotek-al-1/11/2005
7928Well, over all I think the news is negative. I wonder if Corey has come to hateRocky9-1/11/2005
7927Just listened to the presentation. Corey's conservative forecast for LunestFiloF-1/11/2005
7926<i>Remember SGP's problems?</i> This of course is very differenBiomaven-1/11/2005
7925up now...... Special Presentation - Results of JPMorgan Insomnia Survey Corey Dscaram(o)uche-1/11/2005
7924If true, could be very meaningful (on the bad side). Remember SGP's problemquidditch-1/11/2005
7923CNBC says Lunesta delayed due to manufacturing approval issues. EDIT phx.corpoRocky9-1/11/2005
7922ACADIA Pharmaceuticals Announces Partnership With Sepracor Tuesday January 11, 7Icebrg-1/11/2005
7921not archived yet.... the "special presentations" float to the top ofscaram(o)uche-1/10/2005
7920Believe it or not, I missed the presentation. I had problems with the audio. IRocky9-1/10/2005
7919When did Corey become part of David's retinue? Talk about plugs for lunestaquidditch-1/10/2005
7918Does anyone feel that SEPR may be getting a bit ahead of itself at this point? FiloF-1/10/2005
7917As pointed out elsewhere, the JPMorgan agenda is up @ mapdigital.com I would poRocky9-1/5/2005
7916<b>The High Cost of Prescription Placebos</b> By Art Buchwald It hDavid C. Burns-1/1/2005
7915Suddenly an avalanche of approvals, none competitors to SleepyTime <b>ApDavid C. Burns-1/1/2005
7914<<<<"They waited until they had a very good idea that this was rkrw-12/27/2004
7913Insomnia drug maker hires 200 locally, could add more By Mark Hollmer Boston BusIcebrg-12/27/2004
7912If you want your upgrades <i>after</i> the price has spiked, read thBiomaven-12/21/2004
7911The NBIX stumble provides an opportunity for S&P analyst to look slightly letuck-12/21/2004
7910Having two separate NDA's must increase the workload at the FDA and these arBiomaven-12/21/2004
7909But is it then more likely to get approved, rather than approvable? It continuesRocky9-12/21/2004
7908I listened to NBIX CC. they said they should be able to fix issues with submissbio_kruncher-12/21/2004
7907In SEPR's early days they worked on an isomer of an NSAID, ketoprofen. One oBiomaven-12/21/2004
79067:04AM Neurocrine Biosci NDA to be reformated (NBIX) 50.06: Co announced today tBMcV-12/21/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News